ReviewResearch (Washington, D.C.)2026
Postoperative Rebleeding: The Sword of Damocles in Minimally Invasive Surgery for Intracerebral Hemorrhage.
Review in Research (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Surgical intervention versus conservative care in severe hypertensive pontine hemorrhage: a retrospective analysis of clinical outcomes.Frontiers in surgery · 2026Article
- Retrospective clinical study of endoscopic transfrontal approach vs. transSylvian-transinsular craniotomy for hypertensive intracerebral hemorrhage in basal ganglia: efficacy comparison and value of anatomical cognition of Sylvian fissure.Frontiers in surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intracranial hemorrhage (ICH) represents a subtype of stroke characterized by increased mortality and disability rates. Early evacuation of the hematoma is essential for the effective management of ICH. Currently, minimally invasive surgery (MIS) has emerged as a promising alternative to traditional craniotomy by offering advantages, such as reduced operating time, minimal surgical trauma, and accelerated recovery. Nonetheless, postoperative rebleeding remains an important complication that adversely affects the functional outcomes and survival rates of the affected patients. Thus, acquiring a thorough understanding of postoperative rebleeding following MIS for ICH is crucial for enhancing neurological functional outcomes. This review aimed to synthesize current evidence regarding the definition of postoperative rebleeding following MIS for ICH, elucidate the mechanisms contributing to this phenomenon, and identify the associated risk factors, including both surgical and patient-related factors. In addition, the review discusses contemporary strategies for the prevention and management of postoperative rebleeding. Furthermore, it explores prospective advances in dynamic risk prediction and early detection of postoperative rebleeding using artificial intelligence and real-time biosensors. This review offers a reference for clinical practice and guides future studies aimed at reducing the risk of postoperative rebleeding after MIS for ICH, thereby enhancing the outcomes of patients.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.